Over the past decade, biotechnology has grown into a global industry – with global responsibilities. There is no shortage of far-sighted industry leaders who want to tackle neglected-country diseases such as HIV, tuberculosis, malaria and African sleeping sickness. But for decades, the potential of biotechnology in developing countries has gone untapped. Market barriers, funding barriers and information barriers have prevented biotechnology from playing a significant role in the fight to improve global health.